Type | Description |
---|---|
Definition | carboxypeptidase B2 |
Date | Results | Publications |
---|---|---|
2017-04-29 11:02:00 | Results indicate that TAFIa could be a novel biomarker and realistic therapeutic target of chronic thromboembolic pulmonary hypertension. | 28289017 |
2015-01-24 11:44:00 | Thrombin-activatable fibrinolysis inhibitor is activated in an instant blood-mediated inflammatory reaction after intraportal islet transplant. | 24188431 |
2012-12-08 10:59:00 | Carboxypeptidase B2 and complement C3 were more abundant in the cerebrospinal fluid of experimental autoimmune encephalomyelitis rats that did not respond to minocyline treatment. | 22768796 |
2010-01-21 00:00:00 | an increase in circulating TAFIa impairs endogenous clot lysis in a rat model of fibrin deposition | 12958609 |
2010-01-21 00:00:00 | TAFI regulates plasmin activity through its enzymatic activity whereby it reduces the plasminogen-binding capacity of the hepatocytes; gene expression is down-regulated in hepatocyte proliferation for producing a fibrinolytic environment for cell growth | 19386599 |
Type | IDs |
---|---|
Gene |
UniProtKB-ID:
CBPB2_RAT
UniprotKB:
Q9EQV9
UniParc:
UPI00000E6916
EMBL:
BC107447,
AB042598,
BC091133
Ensembl:
ENSRNOG00000010935
KO:
rno:113936
|
Nucleutide sequences |
EMBL-CDS:
AAH91133.1,
AAI07448.1,
BAB18617.1
Ensembl_TRS:
ENSRNOT00000014909
|
Protein sequencees |
Ensembl_PRO:
ENSRNOP00000014909
RefSeq:
NP_446069.1
|
Others |
UniRef100:
UniRef100_Q9EQV9
UniRef90:
UniRef90_Q9EQV9
UniRef50:
UniRef50_Q96IY4
UniGene:
Rn.12572
|
{{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
---|---|---|---|---|---|---|---|---|
Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
暂无数据
排名 | 科研单位 | 文献 |
---|---|---|
{{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
排名 | 研究人员 | 文献 |
---|---|---|
{{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员